| 000 | 00668 a2200229 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20191226214944.0 | ||
| 008 | |||
| 020 | _a9241592370 | ||
| 060 | _aWC 503.1 H 2004 | ||
| 245 | 1 | 0 |
_aHIV assays : _boperational characteristics (Phase 1). |
| 260 |
_aGeneva : _bWorld Health Organization, _c2004. |
||
| 300 |
_a57 p. _bill. _c30 cm. |
||
| 650 | 0 | 2 |
_aEnzyme-linked immunosorbent assay. _98017 |
| 650 | 0 | 2 |
_aHIV antigens _98018 |
| 650 | 0 | 2 |
_aHIV infections _98019 |
| 650 | 0 | 2 |
_aAIDS serodiagnosis _98020 |
| 650 | 0 | 2 |
_aHIV seropositivity _98021 |
| 650 | 0 | 2 |
_aReagent kits, Diagnostic _98022 |
| 650 | 0 | 2 |
_aClinical trials, Phase I. _98023 |
| 942 |
_2NLM _cBK |
||
| 999 |
_c2508 _d2508 |
||